SecBot SecBot
144 ·Filed Nov 2, 2026

RDY

DR REDDYS LABORATORIES LTD
BEARISH
Impact 5/10
Horizonimmediate Processed14d 15h ago SEC0001628280-26-068742
Form 144: notice of proposed sale of securities
Actionable Insight ▼ Bearish

The CEO's intent to sell a very large block of shares (over 7% of market cap) is a strong negative signal. Monitor for actual execution on Form 4 and any subsequent insider selling patterns.

DirectionBearish
Confidencehigh
Horizonimmediate

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$14.13
T+0 close · Nov 2, 2026 · via day close
Latest settled
+6.51%
T+5 · $15.05 · next T+20 in 14d
Vs SPY
+6.43%
α at T+5
Latest observation
+4.68%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $14.13entry
  2. T+1 · 14d ago +1.20%α +0.90% · $14.30
  3. T+5 · 8d ago +6.51%α +6.43% · $15.05
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Erez Israeli filed a Form 144 notice of intent to sell 460,726 ADRs of Dr. Reddy's Laboratories, valued at approximately $834.6 million based on the filing's reference price. This represents a substantial portion of the CEO's holdings and is a significant insider sale signal.

Key Facts

  • CEO Erez Israeli filed Form 144 to sell 460,726 ADRs
  • Approximate market value of proposed sale: $834.6 million
  • Shares acquired via stock options exercised on 10/28/2026
  • Filing date: 2026-11-02; proposed sale date: 10/29/2026 (already past at filing)
  • Broker: Merrill Lynch, 75 Rockefeller Plaza, New York

Financial Impact

CEO proposes to sell 460,726 ADRs worth ~$834.6 million, a very large insider sale relative to market cap of $11.8B (approx. 7.1% of market cap)

dilutioninsider ownership

Risk Factors

  • Form 144 is only an intent to sell; the sale may not be completed
  • The proposed sale date (10/29/2026) precedes the filing date (11/02/2026), suggesting the sale may have already occurred or is imminent
  • Large insider sale by CEO could indicate lack of confidence or personal liquidity needs

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
45% bullish (42 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-068742
Document: 0001628280-26-068742-index.html0001628280-26-068742
Document: 0001628280-26-068742.txt0001628280-26-068742

Track record

73 reports on RDY

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Viewing Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026